Peptide Sequence, Analog, or Formulation Patentability Search

Ideal For:
Peptide therapeutics startups, university spinouts, and research teams with a novel sequence, modification (such as cyclization, lipidation, D-amino acids, or stapling), delivery approach, or formulation who need to know whether to file.

Includes:

• Review of the invention disclosure for a single peptide or closely related family
• Sequence-based search of patent and published application databases, plus a keyword and classification search
• Sequence Screen: closest-reference identification for the core sequence
• Standard Report: all of the above plus modification, formulation, and method-of-use searching, non-patent literature, a novelty and obviousness discussion, and a patent-eligibility check for naturally occurring sequences
• Written Opinion: all of the above plus a formal written patentability opinion with claim-strategy recommendations

Excludes:

• Commercial sequence database fees and other third-party fees (billed at cost)
• Freedom-to-operate or infringement analysis
• Drafting or filing an application
• Foreign or PCT searches
• Additional peptide families not listed in the engagement letter

Deliverables:
Sequence Screen: short written summary of closest references. Standard Report: written search report and a 30-minute review call. Written Opinion: formal written opinion and a 45-minute review call.

Typical Turnaround:
Sequence Screen 1–2 weeks. Standard Report 2–4 weeks. Written Opinion 4–5 weeks.